Privia Health Group, Inc. (PRVA) Tops Q2 EPS by 12c; Offers Guidance

Privia Health Group, Inc. (NASDAQ: PRVA) reported Q2 EPS of $0.19, $0.12 better than the analyst estimate of $0.07. Revenue for the quarter came in at $632.6 million versus the consensus estimate of $597.76 million.

FY2026 Outlook-

Revenue between $2.35 billion to 2.45 billion versus the consensus $2.42 billion.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies